{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:56:40Z","timestamp":1774504600355,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.nmd.2026.106368","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:07:40Z","timestamp":1770307660000},"page":"106368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal assessment of respiratory status utilising the amended Great Ormond Street Respiratory Score in treated spinal muscular atrophy type 1 children"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-5388","authenticated-orcid":false,"given":"Lisa","family":"Edel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Stimpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Patelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacristina","family":"Scoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Baranello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-190424","article-title":"Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care","volume":"7","author":"Schorling","year":"2020","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.nmd.2026.106368_bib0002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.nmd.2021.01.008","article-title":"A new respiratory scoring system for evaluation of respiratory outcomes in children with spinal muscular atrophy type1 (SMA1) on SMN enhancing drugs","volume":"31","author":"Edel","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.106368_bib0003","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.sleep.2025.02.034","article-title":"Differential respiratory function response in paediatric spinal muscular atrophy types 2 and 3 treated with nusinersen over 3 years","volume":"129","author":"Chacko","year":"2025","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.nmd.2026.106368_bib0004","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ppul.25899","article-title":"Respiratory management of spinal muscular atrophy type 1 patients treated with Nusinersen","volume":"57","author":"Menard","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2026.106368_bib0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpn.2024.06.004","article-title":"An updated systematic review on spinal muscular atrophy patients treated with nusinersen, onasemnogene abeparvovec (at least 24 months), risdiplam (at least 12 months) or combination therapies","volume":"51","author":"Giess","year":"2024","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15175","article-title":"Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen","volume":"64","author":"Ergenekon","year":"2022","journal-title":"Pediatr Int"},{"issue":"7","key":"10.1016\/j.nmd.2026.106368_bib0007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"issue":"10063","key":"10.1016\/j.nmd.2026.106368_bib0008","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.nmd.2026.106368_bib0009","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2102047","article-title":"Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls","volume":"385","author":"Darras","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nmd.2026.106368_bib0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","article-title":"Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial","volume":"20","author":"Day","year":"2021","journal-title":"Lancet Neurol"},{"issue":"10479","key":"10.1016\/j.nmd.2026.106368_bib0011","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(25)00048-0","article-title":"Spinal muscular atrophy in the UK: the human toll of slow decisions","volume":"405","author":"Servais","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.nmd.2026.106368_bib0012","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JND-190428","article-title":"One Year of Newborn Screening for SMA - Results of a German Pilot Project","volume":"6","author":"Vill","year":"2019","journal-title":"J Neuromuscul Dis"},{"issue":"14","key":"10.1016\/j.nmd.2026.106368_bib0013","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000006281","article-title":"Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: a cohort study","volume":"91","author":"Aragon-Gawinska","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2026.106368_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"issue":"18","key":"10.1016\/j.nmd.2026.106368_bib0015","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/thoraxjnl-2020-216564","article-title":"Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3","volume":"77","author":"Chacko","year":"2022","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.nmd.2026.106368_bib0017","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ppul.25209","article-title":"Respiratory outcomes post nusinersen in spinal muscular atrophy type 1","volume":"56","author":"Gonski","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ppul.25140","article-title":"Nusinersen for spinal muscular atrophy type 1: real-world respiratory experience","volume":"56","author":"Lavie","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2026.106368_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpeds.2019.12.047","article-title":"Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen","volume":"219","author":"Sansone","year":"2020","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.nmd.2026.106368_bib0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3233\/JND-230248","article-title":"A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA)","volume":"11","author":"Marti","year":"2024","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.nmd.2026.106368_bib0021","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ppul.25135","article-title":"The respiratory impact of novel therapies for spinal muscular atrophy","volume":"56","author":"Paul","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0022","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ppul.26173","article-title":"Respiratory characteristics in children with spinal muscular atrophy type 1 receiving nusinersen","volume":"58","author":"Xiao","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2026.106368_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.16387","article-title":"Bulbar function in children with spinal muscular atrophy type 1 treated with nusinersen","author":"Stimpson","year":"2025","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2026.106368_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231154335","article-title":"Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy","volume":"16","author":"Ngawa","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"issue":"12","key":"10.1016\/j.nmd.2026.106368_bib0025","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S1474-4422(22)00339-8","article-title":"Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial","volume":"21","author":"Masson","year":"2022","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00431-024-05886-9","article-title":"Respiratory outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy: national real-world cohort study","volume":"184","author":"Lavie","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"21","key":"10.1016\/j.nmd.2026.106368_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216306","article-title":"The Impact of Nusinersen Treatment on Respiratory Function in Patients with Spinal Muscular Atrophy: a Systematic Review","volume":"13","author":"Aldukain","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2026.106368_bib0028","first-page":"1","article-title":"Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen","author":"Gauvreau","year":"2025","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2026.106368_bib0029","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1164\/rccm.202111-2577LE","article-title":"Can Breathing Pattern Assessment Predict the Need of Ventilatory Support in Treated Infants with Spinal Muscular Atrophy Type 1?","volume":"206","author":"LoMauro","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nmd.2026.106368_bib0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fneur.2018.00703","article-title":"A New Method for Measuring Bell-Shaped Chest Induced by Impaired Ribcage Muscles in Spinal Muscular Atrophy Children","volume":"9","author":"LoMauro","year":"2018","journal-title":"Front Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:57:29Z","timestamp":1774497449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"alternative-id":["S0960896626000362"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106368","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal assessment of respiratory status utilising the amended Great Ormond Street Respiratory Score in treated spinal muscular atrophy type 1 children","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.106368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106368"}}